SUBSCRIBE
SUBSCRIBE

Biogen

NEWS
Biotech Vets Launch Arrakis With $38 Million and Will be Helmed By Biogen Alum Michael Gilman
Genetown
Biotech Vets Launch Arrakis Therapeutics With $38 Million and Will be Helmed By Biogen Alum Michael Gilman
February 27, 2017
 · 
2 min read
Genetown
Top Pharma Lobbyist Showers Praise on Biogen for Being Anti-Shkreli Like
February 22, 2017
 · 
1 min read
Celgene Cuddles Up With Another Cambridge Biotech, This Time to Tackle Autoimmune Diseases
Drug Development
This Drug Could Rattle Biogen and Be the Next Billion-Dollar Blockbuster for Celgene
February 20, 2017
 · 
2 min read
Drug Development
Merck & Co.'s Alzheimer’s Failure Has All Eyes and Hopes Turning to Biogen
February 16, 2017
 · 
1 min read
Investors Sigh With Relief as Biogen's Alzheimer's Drug Delivers in Early-Stage Study
Genetown
This Could be Biogen’s Next $1 Billion Blockbuster
February 8, 2017
 · 
2 min read
Wall Street's Top Biotech Analyst Loves These 2 Life Science Stocks
Drug Development
Why This Big Biotech Could be Biogen’s Downfall
February 2, 2017
 · 
2 min read
Wall Street's Top Biotech Analyst Loves These 2 Life Science Stocks
Business
Launching This Week, A Look at Biogen’s Spinoff Bioverativ
January 30, 2017
 · 
2 min read
Wall Street's Top Biotech Analyst Loves These 2 Life Science Stocks
Deals
Why Celgene Should Consider Buying Rival Biogen
January 24, 2017
 · 
2 min read
Wall Street's Top Biotech Analyst Loves These 2 Life Science Stocks
Business
Earnings Preview: Here’s a Look at What to Expect From 7 Biopharmas
January 23, 2017
 · 
3 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2023 Best Places to Work
JOBS
IN THE PRESS
Genetown
Biogen Idec, Inc. (Massachusetts) Prices New MS Pill Below Rival Meds
April 1, 2013
 · 
1 min read
FDA
Biogen Idec, Inc. (Massachusetts) Wins FDA Approval for Blockbuster Oral MS Drug
March 28, 2013
 · 
9 min read
Genetown
Biogen Idec, Inc. (Massachusetts) Multiple Sclerosis Drug Wins EU Agency’s Backing
March 22, 2013
 · 
6 min read
Genetown
Biogen Idec, Inc. (Massachusetts) Release: U.S. Patent Office Grants Patent Claiming Dosing Regimen for TECFIDERA™ (Dimethyl Fumarate)
March 20, 2013
 · 
1 min read
Drug Development
Biogen Idec, Inc. (Massachusetts)'s Injectable MS Drug Cut Relapse Rate by 36 Pct
March 20, 2013
 · 
5 min read
Policy
Biogen Idec, Inc. (Massachusetts) Submits Application to FDA for First Long-Lasting Factor VIII Therapy for Hemophilia A
March 12, 2013
 · 
1 min read
Policy
Biogen Idec, Inc. (Massachusetts) Asked in Suit to Return ALS Biosamples to Knopp NeuroSciences
March 11, 2013
 · 
1 min read
Genetown
Biogen Idec, Inc. (Massachusetts), Forest Laboratories, Inc. and Bayer AG Among Top Sponsors Rated by Investigative Sites in New CenterWatch Inc. Survey
March 4, 2013
 · 
1 min read
Policy
FDA Accepts Biogen Idec, Inc. (Massachusetts)'s Biologics License Application for First Long-Lasting Factor IX Therapy for Hemophilia B
March 4, 2013
 · 
1 min read
Genetown
Biogen Idec, Inc. (Massachusetts) to Present at the Cowen and Company 33rd Annual Healthcare Conference
February 28, 2013
 · 
1 min read
Load More